Skip to content

v6.0.0

Choose a tag to compare

View all tags
@github-actions github-actions released this 21 Nov 15:59
· 3141 commits to main since this release
v6.0.0
c46a4f5
This commit was created on GitHub.com and signed with GitHub’s verified signature.
GPG key ID: B5690EEEBB952194
Verified
Learn about vigilant mode.

Full Changelog: v5.10.0...v6.0.0

Enabling MMR

  • Add MMR to all teams (MAV-2493) - Enabling functionality for MMR vaccine in Mavis built in and hidden in previous releases

Cohorting/ Eligibility/ Vaccination History

  • MAV-2070: MAVIS will now check MMR eligibility using the Green Book rules. Children must have had two valid doses: - The first after their first birthday, and - The second at least 28 days later and after 15 months of age.

  • MAV-2067: This ticket is to add the 2 MMR vaccines (Priorix and MMRProVax) approved for use. Both share the same SNOMED procedure code.

  • MAV-2082: This change replaces the single "Programme outcome" field with four clearer vaccination statuses: Not eligible, Eligible, Due, and Vaccinated. This helps teams better understand each child's current vaccination status and reduces ambiguity in reporting and planning. This adds the eligibility criteria for MMR, ensuring that the patients are given the right statuses. To achieve this, vaccination status labels are being updated for all programmes to clearly distinguish between the various statuses. For MMR specifically, new statuses will show whether a child is due or eligible for the first or second dose. This change impacts all programmes.

Consent (parent journey)

  • MAV-2068: A new MMR vaccination programme is being introduced in MAVIS to support catch-ups in line with the national SAIS specification. This allows SAIS teams to assess MMR status and offer vaccinations alongside existing programmes (HPV, Td/IPV, MenACWY) or in community clinics.

  • MAV-2430: Research with parents found that the consent process for MMR and other vaccination programmes could be clearer and more supportive, particularly for those choosing not to consent. This update adds clearer wording and helpful hints to make the consent journey easier to understand and less discouraging for parents who refuse consent.

  • MAV-2379: Clearer messaging is being added to consent confirmation emails for MMR and flu vaccines to make it obvious to parents which vaccine type they've agreed to particularly whether it contains gelatine or not.

  • MAV-2074: This change adds the consent process for the MMR vaccination. Parents can now give or refuse consent online, and they'll be asked if they are happy for their child to have a vaccine that contains gelatine. SAIS teams can also record verbal consent for MMR in MAVIS.

  • MAV-2384: A PDF version of the consent form that SAIS teams can print out or share with schools.

  • MAV-2445: All live consent request emails normally include the child's name in the subject line, as this helps parents recognise the message and respond more quickly. It was identified that the MMR consent request email did not include the child's name. This change updates the MMR consent email template so the child's name appears in the subject line (e.g. "Consent for [Child's Name] to receive the MMR vaccine").

  • MAV-2446: Parents currently receive a "Vaccination confirmed" email after their child receives an MMR vaccination. This change adds variable content to the confirmation email to clearly inform parents that a second dose of MMR is needed for full protection. The additional text will only appear when a child has received their first dose of MMR.

Consent (SAIS) and triaging consent responses

  • MAV-2425: When recording triage for the MMR programme, nurses will now need to choose whether the child can safely receive the gelatine-containing or non-gelatine MMR vaccine. This could lead to uncertainty or delays if a child had religious, cultural, or medical reasons to avoid gelatine-based vaccines.

  • MAV-2290: MMR is a live vaccine and should not be given within 4 weeks of another live vaccine (e.g. previous MMR, nasal flu, yellow fever) unless both are given on the same day. This change updates MAVIS to better manage children who must wait before receiving their next MMR dose.

  • MAV-2075: When recording triage for the MMR programme, nurses will now need to choose whether the child can safely receive the gelatine-containing or non-gelatine MMR vaccine. This could lead to uncertainty or delays if a child had religious, cultural, or medical reasons to avoid gelatine-based vaccines.

  • MAV-2303: Nurses can now manually triage MMR patients even if the consent responses say no triage needed. This allows them to review and act on new or important medical information added by parents or received after consent was submitted. Other vaccination programmes are not affected.

Recording and reporting vaccinations / Dashboard and Programme View

  • MAV-2347: The pre-screening questions shown before vaccination are being updated to better reflect what nurses actually review in practice.

  • MAV-2296: This update adds the basic functionality needed to record MMR vaccinations. It filters vaccine options so that only suitable vaccines are shown based on whether the patient can have vaccines containing gelatine. The current version does not yet include the ability to pick the correct dose (for example, first or second dose) when recording the vaccination.

  • MAV-2426: When recording MMR vaccinations, they should be only offered the appropriate product (with or without gelatine) based on the consent and the triage status.

  • MAV-2448: Allow SAIS teams to record MMR vaccinations offline and import them back into Mavis when they're back online.

  • MAV-2103: This change adds standardised MMR vaccine side effect information to MAVIS, following the approved content in the clinical prototype. This ensures that both parents and staff receive accurate, consistent, and updated information when recording or reviewing consent.

Assets 2
Loading